Quesada A R, García Grávalos M D, Fernández Puentes J L
Facultad de Ciencias, Universidad de Málaga, Spain.
Br J Cancer. 1996 Sep;74(5):677-82. doi: 10.1038/bjc.1996.421.
The effects of several members of the family of lamellarins, polyaromatic alkaloids isolated from tunicates belonging to the genus Didemnum, on the growth of several tumour cell lines and on P-glycoprotein (P-gp)-mediated multidrug resistance (MDR), were investigated. Cytotoxicity experiments of lamellarins were performed on a panel of tumour cell lines, including two multidrug-resistant cell lines. Some lamellarins showed good anti-tumour activity, with similar levels of cytotoxicity against both the resistant and their corresponding parental cell lines. Two lamellarins displayed a high potency against lung carcinoma cells. Studies of the resistance modifier activity of the different lamellarins at non-toxic concentrations were also carried out in cells exhibiting MDR, and lamellarin I was selected for the highest chemosensitising activity. At non-toxic doses, verapamil and lamellarin I effectively increased the cytotoxicity of doxorubicin, vinblastine and daunorubicin in a concentration-dependent manner in multidrug-resistant cells, but the potency of lamellarin I as a MDR modulator was 9- to 16-fold higher than that of verapamil. In vitro measurements of rhodamine 123 accumulation in the multidrug-resistant Lo Vo/Dx cells suggest that lamellarin I reverses MDR by directly inhibiting the P-gp-mediated drug efflux. This work underscores the possibility of using these marine-derived compounds as a potential new source of anti-tumoral drugs active on resistant cells as well as of non-toxic modulators of the MDR phenotype.
从Didemnum属被囊动物中分离得到的层状素家族(一类多环生物碱)的几种成员对几种肿瘤细胞系生长及P-糖蛋白(P-gp)介导的多药耐药性(MDR)的影响进行了研究。对包括两种多药耐药细胞系在内的一组肿瘤细胞系进行了层状素的细胞毒性实验。一些层状素显示出良好的抗肿瘤活性,对耐药细胞系及其相应的亲本细胞系具有相似水平的细胞毒性。两种层状素对肺癌细胞表现出高效力。还在表现出MDR的细胞中进行了不同层状素在无毒浓度下的耐药修饰活性研究,层状素I被选为化学增敏活性最高的。在无毒剂量下,维拉帕米和层状素I在多药耐药细胞中以浓度依赖方式有效增加了阿霉素、长春碱和柔红霉素的细胞毒性,但层状素I作为MDR调节剂的效力比维拉帕米高9至16倍。对多药耐药的Lo Vo/Dx细胞中罗丹明123积累的体外测量表明,层状素I通过直接抑制P-gp介导的药物外排来逆转MDR。这项工作强调了使用这些海洋来源化合物作为对耐药细胞有活性的潜在新型抗肿瘤药物以及MDR表型无毒调节剂的可能性。